Interpretation of the Recommendation Statement by the USPSTF on the Screening for Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease (COPD) is a common disease that seriously harms human health, and it is also a leading cause of death, with a large number of cases being underdiagnosed. Can COPD screening enable early diagnosis of the disease and improve patient outcomes? In 2022, the U.S. Pre...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Chinese General Practice Publishing House Co., Ltd
2024-05-01
|
| Series: | Zhongguo quanke yixue |
| Subjects: | |
| Online Access: | https://www.chinagp.net/fileup/1007-9572/PDF/20230875.pdf |
| _version_ | 1797216489826156544 |
|---|---|
| author | YANG Ziyu, ZHANG Rui, LIAO Xiaoyang, LEI Yi, JIA Yu, YANG Rong, LI Dongze |
| author_facet | YANG Ziyu, ZHANG Rui, LIAO Xiaoyang, LEI Yi, JIA Yu, YANG Rong, LI Dongze |
| author_sort | YANG Ziyu, ZHANG Rui, LIAO Xiaoyang, LEI Yi, JIA Yu, YANG Rong, LI Dongze |
| collection | DOAJ |
| description | Chronic obstructive pulmonary disease (COPD) is a common disease that seriously harms human health, and it is also a leading cause of death, with a large number of cases being underdiagnosed. Can COPD screening enable early diagnosis of the disease and improve patient outcomes? In 2022, the U.S. Preventive Services Task Force (USPSTF) updated its "Chronic Obstructive Pulmonary Disease Screening Recommendation Statement" (hereinafter referred to as the "Recommendation") for asymptomatic adults by evaluating the latest research evidence regarding the benefits and harms of COPD screening. Based on limited evidence, the USPSTF issused a 'D' statement (there is moderate certainty that the screening has no net benefit) and recommends against COPD screening for asymptomatic adults, which is consistent with the 2016 version. The current article interprets the principles of this Recommendation in the context of Chinese general practice. |
| first_indexed | 2024-04-24T11:46:47Z |
| format | Article |
| id | doaj.art-4aef79328aa041fa8713f34eb12be347 |
| institution | Directory Open Access Journal |
| issn | 1007-9572 |
| language | zho |
| last_indexed | 2024-04-24T11:46:47Z |
| publishDate | 2024-05-01 |
| publisher | Chinese General Practice Publishing House Co., Ltd |
| record_format | Article |
| series | Zhongguo quanke yixue |
| spelling | doaj.art-4aef79328aa041fa8713f34eb12be3472024-04-09T09:34:17ZzhoChinese General Practice Publishing House Co., LtdZhongguo quanke yixue1007-95722024-05-0127141661166510.12114/j.issn.1007-9572.2023.0875Interpretation of the Recommendation Statement by the USPSTF on the Screening for Chronic Obstructive Pulmonary DiseaseYANG Ziyu, ZHANG Rui, LIAO Xiaoyang, LEI Yi, JIA Yu, YANG Rong, LI Dongze0General Practice Medical Center, West China Hospital, Sichuan University, Chengdu 610041, ChinaChronic obstructive pulmonary disease (COPD) is a common disease that seriously harms human health, and it is also a leading cause of death, with a large number of cases being underdiagnosed. Can COPD screening enable early diagnosis of the disease and improve patient outcomes? In 2022, the U.S. Preventive Services Task Force (USPSTF) updated its "Chronic Obstructive Pulmonary Disease Screening Recommendation Statement" (hereinafter referred to as the "Recommendation") for asymptomatic adults by evaluating the latest research evidence regarding the benefits and harms of COPD screening. Based on limited evidence, the USPSTF issused a 'D' statement (there is moderate certainty that the screening has no net benefit) and recommends against COPD screening for asymptomatic adults, which is consistent with the 2016 version. The current article interprets the principles of this Recommendation in the context of Chinese general practice.https://www.chinagp.net/fileup/1007-9572/PDF/20230875.pdfpulmonary disease, chronic obstructive|u.s. preventive services task force|screening|recommendation|interpretation |
| spellingShingle | YANG Ziyu, ZHANG Rui, LIAO Xiaoyang, LEI Yi, JIA Yu, YANG Rong, LI Dongze Interpretation of the Recommendation Statement by the USPSTF on the Screening for Chronic Obstructive Pulmonary Disease Zhongguo quanke yixue pulmonary disease, chronic obstructive|u.s. preventive services task force|screening|recommendation|interpretation |
| title | Interpretation of the Recommendation Statement by the USPSTF on the Screening for Chronic Obstructive Pulmonary Disease |
| title_full | Interpretation of the Recommendation Statement by the USPSTF on the Screening for Chronic Obstructive Pulmonary Disease |
| title_fullStr | Interpretation of the Recommendation Statement by the USPSTF on the Screening for Chronic Obstructive Pulmonary Disease |
| title_full_unstemmed | Interpretation of the Recommendation Statement by the USPSTF on the Screening for Chronic Obstructive Pulmonary Disease |
| title_short | Interpretation of the Recommendation Statement by the USPSTF on the Screening for Chronic Obstructive Pulmonary Disease |
| title_sort | interpretation of the recommendation statement by the uspstf on the screening for chronic obstructive pulmonary disease |
| topic | pulmonary disease, chronic obstructive|u.s. preventive services task force|screening|recommendation|interpretation |
| url | https://www.chinagp.net/fileup/1007-9572/PDF/20230875.pdf |
| work_keys_str_mv | AT yangziyuzhangruiliaoxiaoyangleiyijiayuyangronglidongze interpretationoftherecommendationstatementbytheuspstfonthescreeningforchronicobstructivepulmonarydisease |